Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Qiaoxia Zhou"'
Publikováno v:
Advanced Science, Vol 11, Iss 14, Pp n/a-n/a (2024)
Abstract Intracellular delivery of nano‐drug‐carriers (NDC) to specific cells, diseased regions, or solid tumors has entered the era of precision medicine that requires systematic knowledge of nano‐biological interactions from multidisciplinary
Externí odkaz:
https://doaj.org/article/9c1965f778b74138a6f8cca995b8bb7f
Autor:
Sujun Han, Yu Xu, Dong Chen, Feiya Yang, Mingshuai Wang, Qiaoxia Zhou, Guoqiang Wang, Leo Li, Chunwei Xu, Wenxian Wang, Shangli Cai, Nianzeng Xing
Publikováno v:
iScience, Vol 27, Iss 1, Pp 108290- (2024)
Summary: The evolutionarily conserved Notch pathway, involved in cancer stem cell capacity and cancer immunity, may predict the benefit from immune checkpoint inhibitors (ICIs) in clear cell renal cell carcinoma (ccRCC). In the TCGA dataset, mRNA exp
Externí odkaz:
https://doaj.org/article/9f0b266ea75c42bd9eab268846484edc
Autor:
Qiaoxia Zhou, Libo Yan, Baofu Xu, Xue’er Wang, Xuehong Sun, Ning Han, Hong Tang, Feijun Huang
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Abstract Hepatitis B virus (HBV) X protein (HBx) has been determined to play a crucial role in the replication and transcription of HBV, and its biological functions mainly depend on the interaction with other host proteins. This study aims at screen
Externí odkaz:
https://doaj.org/article/72c24939c057419794e5340abc3cd0be
Autor:
Zhiyu Wang, Zhuoqi Zhang, Ke Zhang, Qiaoxia Zhou, Sidong Chen, Hao Zheng, Guoqiang Wang, Shangli Cai, Fujing Wang, Shenglong Li
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundGlycerolipid metabolism is involved in the genesis and progression of colon cancer. The current study aims at exploring the prognostic value and potential molecular mechanism of glycerolipid metabolism-related genes in colon cancer from the
Externí odkaz:
https://doaj.org/article/8aa9ffdcfffe4e21af2acedc349c84cb
Autor:
Suihui Li, Jinfeng Zhu, Tengfei Zhu, Yu Xu, Wenxi Chen, Qiaoxia Zhou, Guoqiang Wang, Leo Li, Yusheng Han, Chunwei Xu, Wenxian Wang, Shangli Cai, Ruilian Xu, Yu Shao
Publikováno v:
Journal of Gastrointestinal Oncology. 14:599-616
Autor:
Xiaogang Shen, Meng Wang, Wenxi Chen, Yu Xu, Qiaoxia Zhou, Tengfei Zhu, Guoqiang Wang, Shangli Cai, Yusheng Han, Chunwei Xu, Wenxian Wang, Lei Meng, Hao Sun
Publikováno v:
Aging.
Autor:
Qiaoxia Zhou1, Libo Yan2,3, Lingyao Du2,3, Xiaoqiong Tang2,3, Hong Tang2,3 htang6198@hotmail.com
Publikováno v:
Hepatitis Monthly. Feb2021, Vol. 21 Issue 2, p1-7. 7p.
Autor:
Guohong Song, Jiayang Zhang, Qingqing Zhou, Honghua Yan, Ye Sun, Meiyu Wang, Ruyan Zhang, Qiaoxia Zhou, Hanfang Jiang, Huiping Li, Youzhi Tong, Yaxin Liu, Qianxiang Zhou, Xunwei Dong, Liandong Ma, Ran Ran, Luping Meng
Publikováno v:
Breast Cancer Research and Treatment
Purpose To evaluate GT0918, a 2nd-generation AR antagonist, for its AR down-regulation activity among breast cancer patients. Methods The effect of GT0918 on AR protein expression was evaluated in AR expression breast cancer cells and in breast cance
Autor:
Ruyan Zhang, Huiping Li, Ran Ran, Qiaoxia Zhou, Luping Meng, Hanfang Jiang, Guohong Song, Youzhi Tong, Ke Chen, Phoebe Zhang, Yaxin Liu, Karl Zhou
Publikováno v:
Cancer Research. 80:P2-17
Background: Androgen receptor (AR) blocker has become an increased interest in the treatment of BC, in which about 60-80% patients showed AR positive. However, currently no AR blocker has been approved in mBC. GT0918 is a new chemical entity of AR bl
Autor:
Wei Zhang, Yu Xu, Mengjiang He, Xia Cheng, Hong Zhou, Huangming Hong, Jie Yao, Qiaoxia Zhou, Guoqiang Wang, Shangli Cai, Yusheng Han, Chunwei Xu, Wenxian Wang, Mu Yang, Tongyu Lin
Publikováno v:
SSRN Electronic Journal.